Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - Other
Ratios

Bristol Myers Squibb (BMYMP) Long-Term Debt Issuances (2017 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Long-Term Debt Issuances for 10 consecutive years, with $5.7 billion as the latest value for Q4 2025.

  • Quarterly Long-Term Debt Issuances changed N/A to $5.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.7 billion through Dec 2025, down 55.45% year-over-year, with the annual reading at $5.7 billion for FY2025, 55.45% down from the prior year.
  • Long-Term Debt Issuances for Q4 2025 was $5.7 billion at Bristol Myers Squibb, down from $12.9 billion in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $12.9 billion in Q1 2024, with the low at $4.5 billion in Q4 2023.
  • Average Long-Term Debt Issuances over 4 years is $7.3 billion, with a median of $5.8 billion recorded in 2022.